David Stern

Greater Boston Contact Info
3K followers 500+ connections

Join to view profile

Articles by David

Activity

Join now to see all activity

Volunteer Experience

Publications

  • Catalyst Advisors Completes Three Biopharma CEO Searches

    Symbiomix required a CEO who could orchestrate the mechanics of a successful product launch. But in this case, success of that product demands a distinct culture shift among providers. The company’s lead product, Solosec, treats bacterial vaginosis, which is often either misdiagnosed or not completely cured because patients fail to complete the current multiday treatment, leaving them at greater risk for infection and fertility issues later on. Solosec’s one-dose treatment dramatically…

    Symbiomix required a CEO who could orchestrate the mechanics of a successful product launch. But in this case, success of that product demands a distinct culture shift among providers. The company’s lead product, Solosec, treats bacterial vaginosis, which is often either misdiagnosed or not completely cured because patients fail to complete the current multiday treatment, leaving them at greater risk for infection and fertility issues later on. Solosec’s one-dose treatment dramatically minimizes patient compliance problems and also has advantages in tolerance and safety. But it is significantly more expensive than the traditional therapy, which costs only pennies per pill. For the market to adopt the product, the OB/GYN community would need to change how it views an infection that is more frequently regarded as a nuisance than a threat.David Stern was named CEO of Symbiomix in February. He has a long career in women’s health, including a decade at EMD Serono, where he rose to lead the company’s $1 billion franchise in fertility drugs. Mr. Stern significantly broadened R&D capability by systematically partnering with external organizations, built a global marketing team and oversaw the relationships with key opinion leaders in the medical, research and patient-advocacy communities. His experience with all aspects of the business gave him a deep understanding of the opportunities for innovation in women’s health that Symbiomix’s investors saw as essential for leading a paradigm shift in the market, Catalyst said.

    See publication

  • Alternative Delivery Devices can Differentiate Products in a Crowded Marketplace

    Product Manager Today

  • How to Market Well

    Next Generation Pharmaceutical Magazine

  • C in the CRM is for Culture as well as Customer

    Medical Marketing & Media Magazine

  • eMarketing at the Tipping Point

    Pharmaceutical Executive

    See publication

  • PharmaVoice 100, The first annual 100 most influential Pharmaceutical Executives in the Industry

    PharmaVoice

Honors & Awards

  • 2007 EMD Serono Brand of the year

    EMD Serono

    2007 Gonal-F US Brand of the year

  • 2008 EMD Serono Brand of the year

    EMD Serono

    2008 Serostim US Brand of the Year

  • 2013 Global Award for Leadership and Superior Performance of the Global Fertility Portfolio

    Merck Serono

Languages

  • Hebrew

    -

Recommendations received

2 people have recommended David

Join now to view

More activity by David

View David’s full profile

  • See who you know in common
  • Get introduced
  • Contact David directly
Join to view full profile

Other similar profiles

Explore collaborative articles

We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.

Explore More

Others named David Stern in United States

503 others named David Stern in United States are on LinkedIn

See others named David Stern

Add new skills with these courses

See all courses